RADIATION MONITORING DEVICES, INC. — Department of Health and Human Services STTR Phase I: 102

RADIATION MONITORING DEVICES, INC. — STTR Phase I award from Department of Health and Human Services.

Amount
$299,992
Agency
Department of Health and Human Services · National Institutes of Health
Program / Phase
STTR · Phase I
Topic
102
Solicitation
PA16-303
NAICS
Place of performance
MA
Period
2017-04-03 → 2018-08-02

Description

Project Summary Abstract Radiation therapy is one of the primary therapeutic techniques for treating cancer Nearly two thirds of all cancer patients will receive radiation therapy during their illness with an average of radiation treatment episodes Although largely effective radiation therapy like other forms of cancer treatment has difficulty killing hypoxic regions within solid tumors Cellular hypoxia is associated with radiotherapy resistance resulting in the incomplete killing of cancer cells and leading to recurrence and relapse Thus developing techniques to target the hypoxic core of tumors is a major goal of cancer research Nearly of all breast cancers and of locally advanced breast cancers are hypoxic and their altered metabolism is strongly linked to resistance to radiotherapy and systemic therapy In prostate cancer hypoxia is associated with early biochemical relapse after radiotherapy and also with local recurrence in the prostate gland A variety of approaches are being used to enhance the efficacy of radiation therapy and reduce dose These include the use of nanoparticles to enhance the radiosensitization of tumor tissue reversing radiation resistance in tumor tissue and increasing the radioresistance of healthy tissue In this proposed effort we will develop a new technique that enhances radiation treatment by using a sensitizer that both increases the energy deposited locally within the tumor and generates UV photons in the vicinity of the DNA in cancer cells Our sensitizer consists of scintillating nanoparticles that emit UV radiation capable of both directly damaging the DNA in hypoxic cancer cells In addition these particles will be composed of high atomic number elements with much higher radiation stopping power than the low atomic number elements that make up tissue This will enhance the efficacy of the high energy X rays used in radiation treatment by down converting the X ray photon energy into lower energy X rays and particles which have a much higher energy deposition rate linear energy transfer LET We have performed a preliminary experiment which gave encouraging results showing an increase in cell death using the LuPO scintillating nanoparticles In Phase I of this effort we will model photon transport and energy conversion for both X rays and UV photons and experimentally demonstrate the effectiveness of the concept in vitro In Phase II we will develop size homogenous nanoparticles suitable for use in exhaustive in vitro cell experiments and preclinical studies Project Narrative This project will investigate enhancing the efficacy of radiation treatment of cancer by using scintillating nanoparticle sensitizers that emit UV photons This sensitizer will enhance the treatment in two ways first by generating UV photons in the immediate vicinity of cancer cells which can interact directly with its DNA to cause lethal damage in an oxygen independent way and second by making more efficient use of the X ray energy that strikes the tumor cell by generating softer more tissue absorbent x rays and photoelectrons The end result will be UV generating nanoparticles with a higher efficacy in the treatment of resistant hypoxic cells of the tumor filling an important unmet clinical need